BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21806395)

  • 1. The golden era of vaccine adjuvants.
    Cabrera O; Cuello M; Lastre M; Romeu B; Balboa J; Zayas C; Pérez O
    Expert Rev Vaccines; 2011 Jul; 10(7):1007-9. PubMed ID: 21806395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4th International Workshop in Vaccine Adjuvants and Parasitic Vaccines (adjuvant 2008).
    Pérez O; Harandi AM
    Expert Rev Vaccines; 2008 Oct; 7(8):1151-3. PubMed ID: 18844589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2nd international workshop on Neisseria vaccines (Neisseria vaccines 2009).
    Romeu B; González E; Campa C; Holst J; Pérez O
    Expert Rev Vaccines; 2009 Aug; 8(8):987-92. PubMed ID: 19627182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.
    Vajdy M; Srivastava I; Polo J; Donnelly J; O'Hagan D; Singh M
    Immunol Cell Biol; 2004 Dec; 82(6):617-27. PubMed ID: 15550120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
    De Magistris MT
    Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Immunotherapeutics and Vaccine Summit - CHI's fifth annual meeting - novel vaccines: adjuvants and delivery systems: part 1.
    Jones SD
    IDrugs; 2010 Oct; 13(10):689-91. PubMed ID: 20878588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current adjuvants and new perspectives in vaccine formulation.
    Montomoli E; Piccirella S; Khadang B; Mennitto E; Camerini R; De Rosa A
    Expert Rev Vaccines; 2011 Jul; 10(7):1053-61. PubMed ID: 21806399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel adjuvants & delivery vehicles for vaccines development: a road ahead.
    Mohan T; Verma P; Rao DN
    Indian J Med Res; 2013 Nov; 138(5):779-95. PubMed ID: 24434331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens.
    Dey AK; Srivastava IK
    Expert Rev Vaccines; 2011 Feb; 10(2):227-51. PubMed ID: 21105782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defending the mucosa: adjuvant and carrier formulations for mucosal immunity.
    Lawson LB; Norton EB; Clements JD
    Curr Opin Immunol; 2011 Jun; 23(3):414-20. PubMed ID: 21511452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary vaccine delivery.
    Lu D; Hickey AJ
    Expert Rev Vaccines; 2007 Apr; 6(2):213-26. PubMed ID: 17408371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current vaccine adjuvants: an overview of a diverse class.
    Kensil CR; Mo AX; Truneh A
    Front Biosci; 2004 Sep; 9():2972-88. PubMed ID: 15353330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of size on particulate vaccine adjuvants.
    Shah RR; O'Hagan DT; Amiji MM; Brito LA
    Nanomedicine (Lond); 2014 Dec; 9(17):2671-81. PubMed ID: 25529570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights in mucosal vaccine development.
    Pavot V; Rochereau N; Genin C; Verrier B; Paul S
    Vaccine; 2012 Jan; 30(2):142-54. PubMed ID: 22085556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the cross-fertilization between biotechnology and immunology: current situation in Cuba.
    Lage A
    Vaccine; 2006 Apr; 24 Suppl 2():S2-3-6. PubMed ID: 16823906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Immunotherapeutics and Vaccine Summit - CHI's fifth annual meeting - novel vaccines: adjuvants and delivery systems: part 2.
    Jones SD
    IDrugs; 2010 Oct; 13(10):692-4. PubMed ID: 20878589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymer nanotechnology based approaches in mucosal vaccine delivery: challenges and opportunities.
    Sharma R; Agrawal U; Mody N; Vyas SP
    Biotechnol Adv; 2015; 33(1):64-79. PubMed ID: 25499178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New developments in oral vaccines and mucosal adjuvants.
    Subiza JL; El-Qutob D; Fernandez-Caldas E
    Recent Pat Inflamm Allergy Drug Discov; 2015; 9(1):4-15. PubMed ID: 25669205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances and Potential Applications of Chitosan Nanoparticles as a Delivery Carrier for the Mucosal Immunity of Vaccine.
    Li D; Fu D; Kang H; Rong G; Jin Z; Wang X; Zhao K
    Curr Drug Deliv; 2017; 14(1):27-35. PubMed ID: 27494157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving vaccines by incorporating immunological coadjuvants.
    Fraser CK; Diener KR; Brown MP; Hayball JD
    Expert Rev Vaccines; 2007 Aug; 6(4):559-78. PubMed ID: 17669010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.